Contraception for individuals with sickle cell disease: A systematic review of the literature

Contraception

Volumn 85, Issue 6, 2012, Pages 527-537

  Haddad, Lisa B ^a   Curtis, Kathryn M ^b   Legardy Williams, Jennifer K ^b   Cwiak, Carrie ^a   Jamieson, Denise J ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Contraception; Hormonal; Sickle cell anemia; Systematic review

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NOMEGESTROL ACETATE(3,20 OXO 6 METHYL 17 ALPHA ACETOXY 19 NORPREGNA 4,6 DIENE); UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BONE PAIN; CHOLESTEROL BLOOD LEVEL; CONTRACEPTION; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DEVICE INFECTION; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN C DISEASE; HEMOGLOBIN SC DISEASE; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIMB PAIN; MENORRHAGIA; MENSTRUAL IRREGULARITY; PATIENT SAFETY; PREGNANCY; PREGNANCY COMPLICATION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETICULOCYTE; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SIDE EFFECT; THROMBOEMBOLISM; THROMBOPLASTIN TIME; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ANEMIA, SICKLE CELL; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; MEDLINE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROGESTINS; RISK FACTORS; THROMBOEMBOLISM;

EID: 84860504229     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.10.008     Document Type: Review

References (41)

1. K.L. Hassell Population estimates of sickle cell disease in the U.S Am J Prev Med 38 4 Suppl 2010 S512 S521
2. D.C. Rees, T.N. Williams, and M.T. Gladwin Sickle-cell disease Lancet 376 2010 2018 2031
3. C. Booth, B. Inusa, and S.K. Obaro Infection in sickle cell disease: a review Int J Infect Dis 14 2010 e2 e12
4. J.A. Smith, M. Espeland, R. Bellevue, D. Bonds, A.K. Brown, and M. Koshy Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease Obstet Gynecol 87 1996 199 204 (Pubitemid 26033131)
5. K.D. Larrabee, and M. Monga Women with sickle cell trait are at increased risk for preeclampsia Am J Obstet Gynecol 177 1997 425 428 (Pubitemid 27385724)
6. D.R. Powars, M. Sandhu, J. Niland-Weiss, C. Johnson, S. Bruce, and P.R. Manning Pregnancy in sickle cell disease Obstet Gynecol 67 1986 217 228 (Pubitemid 16135568)
7. S. Charache, and J.R. Niebyl Pregnancy in sickle cell disease Clin Haematol 14 1985 729 746 (Pubitemid 16242427)
8. P.M. Sun, W. Wilburn, B.D. Raynor, and D. Jamieson Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia Am J Obstet Gynecol 184 2001 1127 1130 (Pubitemid 32434263)
9. R.L. Reid, C. Westhoff, and D. Mansour Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009 J Fam Plann Reprod Health Care 36 2010 117 122
10. R.B. Francis Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications Med Hypotheses 35 1991 88 95
11. R.B. Francis Jr Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion Blood Coagul Fibrinolysis 2 1991 341 353
12. K.I. Ataga Hypercoagulability and thrombotic complications in hemolytic anemias Haematologica 94 2009 1481 1484
13. Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006;119:897 e897-811.
14. H. Austin, N.S. Key, and J.M. Benson Sickle cell trait and the risk of venous thromboembolism among blacks Blood 110 2007 908 912 (Pubitemid 47267428)
15. F. DeVenuto Interaction of progesterone and aldosterone with red blood cells of the rat Proc Soc Exp Biol Med 124 1967 478 483
16. L.A. Norris, and J. Bonnar The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives Br J Obstet Gynaeco 103 1996 261 267 (Pubitemid 26075461)
17. P. Mehta, and J. Mehta Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion Stroke 10 1979 464 466 (Pubitemid 9183751)
18. C.A. Papadimitriou, A. Travlou, A. Kalos, D. Douratsos, and P. Lali Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis Acta Haematol 89 1993 180 183 (Pubitemid 23284606)
19. S.K. Ballas, and E.D. Smith Red blood cell changes during the evolution of the sickle cell painful crisis Blood 79 1992 2154 2163
20. F.A. Oski, B. Lubin, and E.D. Buchert Reduced red cell filterability with oral contraceptive agents Ann Intern Med 77 1972 417 419
21. J.R. Durocher, M.S. Weir, E.G. Lundblad, W.E. Patow, and M.E. Conrad Effect of oral contraceptives and pregnancy on erythrocyte deformability and surface charge Proc Soc Exp Biol Med 150 1975 368 370
22. W.C. Yoong, S.M. Tuck, and A. Yardumian The effect of ovarian steroids on sickle cell deformability Clin Lab Haematol 20 1998 151 154 (Pubitemid 28313574)
23. Isaacs WA. The effect of certain lipid substances on sickling. Acta Haematol;45:259-65.
24. W.A. Isaacs, C.E. Effiong, and O. Ayeni Steroid treatment in the prevention of painful episodes in sickle-cell disease Lancet 1 1972 570 571
25. W.A. Isaacs, and F.G. Hayhoe Steroid hormones in sickle-cell disease Nature 215 1967 1139 1142
26. J.K. Legardy, and K.M. Curtis Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review Contraception 73 2006 195 204 (Pubitemid 43087769)
27. A. Manchikanti, D.A. Grimes, L.M. Lopez, and K.F. Schulz Steroid hormones for contraception in women with sickle cell disease Cochrane Database Syst Rev 2007 CD006261
28. A.P. Mohllajee, K.M. Curtis, R.G. Flanagan, W. Rinehart, M.L. Gaffield, and H.B. Peterson Keeping up with evidence a new system for WHO's evidence-based family planning guidance Am J Prev Med 28 2005 483 490 (Pubitemid 40723585)
29. R.P. Harris, M. Helfand, and S.H. Woolf Current methods of the US Preventive Services Task Force: a review of the process Am J Prev Med 20 3 Suppl 2001 S21 S35
30. S.H. O'Brien, J. Klima, S. Reed, D. Chisolm, E.B. Schwarz, and K.J. Kelleher Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims Contraception 83 2011 134 137
31. K. De Ceulaer, C. Gruber, R. Hayes, and G.R. Serjeant Medroxyprogesterone acetate and homozygous sickle-cell disease Lancet 2 1982 229 231 (Pubitemid 12081768)
32. R.J. Howard, C. Lillis, and S.M. Tuck Contraceptives, counselling, and pregnancy in women with sickle cell disease BMJ 306 1993 1735 1737 (Pubitemid 23173722)
33. O.A. Ladipo, A.G. Falusi, P.J. Feldblum, B.O. Osotimehin, E.O. Otolorin, and O. Ojengbede Norplant use by women with sickle cell disease Internl J Gynecol Obstet 41 1993 85 87 (Pubitemid 23115540)
34. M. de Abood, Z. de Castillo, F. Guerrero, M. Espino, and K.L. Austin Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients Contraception 56 1997 313 316 (Pubitemid 28022884)
35. L. Nascimento Mde, O.A. Ladipo, and E.M. Coutinho Nomegestrol acetate contraceptive implant use by women with sickle cell disease Clin Pharmacol Ther 64 1998 433 438 (Pubitemid 28473769)
36. W.C. Yoong, S.M. Tuck, K.J. Pasi, D. Owens, and D.J. Perry Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraception Eur J Haematol 70 2003 310 314 (Pubitemid 36560529)
37. W.C. Yoong, S.M. Tuck, and A. Yardumian Red cell deformability in oral contraceptive pill users with sickle cell anaemia Br J Haematol 104 1999 868 870 (Pubitemid 29143510)
38. I.C. Barbosa, O.A. Ladipo, and M.L. Nascimento Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant) Contraception 63 2001 263 265 (Pubitemid 32607688)
39. R.J. Howard, and S.M. Tuck Contraception and sickle cell disease IPPF Med Bull 28 1994 3 4
40. Austin H, Lally C, Benson JM, Whitsett C, Hooper WC, Key NS. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol 2009;200:620 e621-623.
41. Centers for Disease Control and Prevention U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. Adapted from the World Health Organization Criteria for Contraceptive Use, 4th edition MMWR Early Release 59 2010 ed2010